Who needs a Swiss banker?
Executive Summary
Genentech has $2.3 bil. in cash reserves to use for acquisition and in-licensing agreements, CFO Louis Lavigne tells analysts April 12. "We have been waiting for some time for market valuations within our industry to adjust...and we think that makes some possible opportunities more attractive," he says